Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...
From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...
IOC President Kirsty Coventry is ready to bring back the genetic tests that had been abandoned for over 30 years, and also ...
Kerala faces a third year of high leptospirosis deaths. Learn about the spread, prevention, and urgent need for timely ...
For the first time, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting COVID-19, the ...
Amoebic meningoencephalitis caused more deaths than flu (influenza) and rabies in the state in 2025. The health department ...
The Global Reproductive Genetics Market is estimated to be valued at USD 7.31 Bn in 2025 and is expected to reach USD 16.67 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from ...
TheFly reported on December 22, 2025, that Canaccord reduced the price objective for Tempus AI, Inc. (NASDAQ:TEM) to $80 from ...
Co-Diagnostics ( ($CODX) ) just unveiled an update. On December 5, 2025, Co-Diagnostics’ stockholders approved a reverse stock split ...
Asianet Newsable on MSN
CODX stock plunges to all-time lows on 1-for-30 reverse stock split approval
Shares of Co-Diagnostics Inc. (CODX) slumped 20% to an all-time low after the company announced a 1-for-30 reverse stock ...
Through December 10, the world has seen 502,264 chikungunya cases worldwide, with 291,451 in the Americas region alone ...
At the Special Meeting of Stockholders held on December 5, 2025, the Company's stockholders approved a reverse stock split of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback